100 mg PF-05231023

DRUG2 trials

Sponsors

Pfizer

Conditions

Diabetes Melliuts, Type 2Type 2 Diabetes Mellitus (T2DM)

Phase 1

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

CompletedNCT01673178

PfizerDiabetes Melliuts, Type 2

Start: 2012-10-31End: 2013-09-30Updated: 2015-02-16

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

TerminatedNCT01923389

PfizerType 2 Diabetes Mellitus (T2DM)

Start: 2013-09-30End: 2013-12-31Updated: 2014-09-17